DDM-005 - Application of solid-lipid nanoparticles and pegylated solid dispersions to enhance delivery of nevirapine for HIV/AIDS management

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: DDM-005
• By: AWANYE, Amaka (Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Nigeria)
• Co-author(s): Dr Sunday Abali (Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Port Harcourt, Nigeria)
  Dr Amaka Awanye (Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Port Harcourt, Nigeria)
  Dr Chidozie Ibezim (Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, University of Port Harcourt, Port Harcourt, Nigeria)
  Dr Chinenye Obinna (Department of Animal and Environmental Biology, Faculty of Science, University of Port Harcourt, Port Harcourt, Nigeria)
  Dr Joachim Odigie (Department of Pharmacology, College of Medicine, University of Port Harcourt, Port Harcourt, Nigeria)
  Prof Godswill Onunkwo (Department of Pharmaceutical Technology and Industrial Pharmacy, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, Nsukka, Nigeria)
  
• Abstract:

  Introduction: Nevirapine is a non-nucleoside reverse transcriptase inhibitor that is used with other antiviral drugs in the management of HIV/AIDS especially in the prevention of mother-to-child transmission. Extended release paediatric suspensions of Nevirapine reduces dosing frequency and improves patient compliance. The preparation and..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login